Community Health Network

Recent papers from Community Health Network

1. The Ethics of Bodyoid UseClinical Anatomy · 2026
2. Using RE-AIM and CFIR to develop a subsidized doula program for at-risk underserved pregnant mothersFrontiers in Public Health · 2026
3. Practice-informed implementation: a multi-method approach to map strategies for sustainable tobacco treatment integration within healthcare settingsFrontiers in Health Services · 2026
4. ID #694 The Team Based Spirituality Experience in Multi-Faith Pediatric Neuro-Oncology CareNeuro-Oncology Pediatrics · 2026
5. Central precocious puberty: an Endocrine Society clinical practice guidelineThe Journal of Clinical Endocrinology & Metabolism · 2026
6. A phase 1b, two-arm study of tolododekin alfa (ANK-101) in combination with an anti–PD-1/PD-L1 antibody in participants with advanced non–small cell lung cancer (NSCLC).Journal of Clinical Oncology · 2026
7. Cladribine (CLAD) + low-dose AraC (LDAC) + venetoclax (VEN) in patients with acute myeloid leukemia and high-risk myelodysplastic syndrome: Real-world analysis from a large community-based oncology practice.Journal of Clinical Oncology · 2026
8. Preclinical and clinical evaluation of futibatinib in combination with binimetinib in patients with advanced cancerInvestigational New Drugs · 2026
9. A19-02 Artisan Interim Analysis: Early Treatment With High-dose Treprostinil Reduces Mean Pulmonary Artery Pressure and Improves Risk Status In Pulmonary Arterial HypertensionAmerican Journal of Respiratory and Critical Care Medicine · 2026
10. Phase I Study of Telisotuzumab Adizutecan (Temab-A, ABBV-400), a Novel c-Met Antibody-Drug Conjugate, in Patients With Late-Line Colorectal Cancer and Advanced Solid Tumors.2026
11. Subcutaneous delivery of amivantamab in patients with advanced solid malignancies: the phase 1b PALOMA studyClinical Lung Cancer · 2026
12. Evaluation of a Community-Led, Cross Sector Partnership of Housing, and Healthcare to Optimize Aging: The Unite Care ModelSage Open Aging · 2026
13. New VSED Advance Directive — Progress, but Problems PersistThe Journal of Law Medicine & Ethics · 2025
14. The role of targeted therapies in blastic plasmacytoid dendritic cell neoplasmExpert Opinion on Biological Therapy · 2025
15. A phase I study targeting the APE1/Ref-1 redox signaling protein with APX3330: first clinical agent targeting APE1/Ref-1 in cancerThe Oncologist · 2025
16. Feasibility and tolerability of a CD4 re-directed chimeric antigen receptor T cell therapy (CD4CAR) in hematologic malignancies: Initial Results from multi-institutional first-in-human trialsBlood · 2025
17. Efficacy and Safety of Olomorasib in Combination With Pembrolizumab in Treatment of Patients With KRAS G12C-Mutant Advanced NSCLCJournal of Thoracic Oncology · 2025
18. Diagnosis and treatment options for chronic abdominal pain after Roux-en-Y gastric bypassSurgery for Obesity and Related Diseases · 2025
19. Real-world data and clinical experience from over 100,000 multi-cancer early detection testsNature Communications · 2025
20. Physical and Occupational Therapy Utilization After Infant Abdominal Surgery.2025